Publications by authors named "Jyoti D Patel"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

21

Total Likes

339

Extended Reach

635,403

Social Features

139
R
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).
Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev

JCO Precis Oncol· September 2023

Videos about Article: user

1 27 6

View All Article and Social Media Activity
E
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.
Alexander Drilon, Daniel S W Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima

JCO Precis Oncol· January 2022

Videos about Article: user

1 2 108 4

View All Article and Social Media Activity
A
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status.
Lyudmila Bazhenova, J G Hodgson, D Ross Camidge, Corey J Langer, Rudolf M Huber, Jyoti D Patel

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Incidental Germline BRCA1/2 and PALB2 Alterations on EGFR Monotherapy Real-World Outcomes for Patients With Advanced Non-Small-Cell Lung Cancer.
Chetan V Vakkalagadda, Leslie Bucheit, Keelia Clemens, Jayati Saha, Nicole Zhang, Jyoti D Patel

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study.
Martin Reck, Jyoti D Patel, Jhanelle E Gray, Noemí Reguart, Manuel Cobo

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status-A Real-World Analysis in Patients With Advanced NSCLC.
David J Cantor, Halla Nimeiri, Leora Horn, Matthew West, Rotem Ben-Shachar, Jyoti D Patel

Clin Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing immune-checkpoint inhibitors: Opportunities for the future.
Won Jin Jeon, So Young Son, Faith Abodunrin, Anisha Khanna, Jyoti D Patel

Curr Probl Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.
Philip C Mack, Mary W Redman, Hanna Tukachinsky, David E Kozono, Katherine Minichiello, Jyoti D Patel

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3.
Dwight H Owen, Nofisat Ismaila, Amith Ahluwalia, Jill Feldman, Shirish Gadgeel, Jyoti D Patel

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Severe brigatinib-induced pneumonitis in a patient with EML4-ALK+ metastatic non-small cell lung adenocarcinoma.
Khyati Somayaji Dasika, Megan Melody, Jyoti D Patel

Front Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve -Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).
Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung Cancer.
Samuel S Kim, David T Cooke, Biniam Kidane, Luis F Tapias, John F Lazar, Jyoti D Patel

Ann Thorac Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes.
Yong Peng, Jason Karpus, Jyoti D Patel, Everett E Vokes, Marina Chiara Garassino

Cancer Commun (Lond)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Next-Generation Sequencing Workflows on Outcomes in Advanced Lung Cancer: A Retrospective Analysis at One Academic Health System.
Chetan V Vakkalagadda, Danielle B Dressler, Zequn Sun, Joseph Fuchs, Yingzhe Liu, Jyoti D Patel

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy.
Ryan D Gentzler, John Guittar, Akash Mitra, Wade T Iams, Terri Driessen, Jyoti D Patel

Oncol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials.
Connor Lynch, Mark C Korpics, Rohan R Katipally, Christine M Bestvina, Sean P Pitroda, Jyoti D Patel

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy for Stage IV Non-Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights.
Dwight H Owen, Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Narjust Florez, Jyoti D Patel

JCO Oncol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma.
Erik Wu, Joseph Reznicek, Anjana V Yeldandi, Jyoti D Patel, David D Odell

Clin Lung Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Jyoti D Patel

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Jyoti D Patel

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
Ryan D Gentzler, Nisha A Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Jyoti D Patel

Oncologist· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion.
Sandip Patel, Jyoti D Patel

Adv Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley, Jyoti D Patel

Lung Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Trastuzumab Deruxtecan to Selpercatinib in a Patient With RET Fusion-Driven NSCLC and an Acquired HER2 Amplification: Case Report.
Chetan V Vakkalagadda, Jyoti D Patel

JTO Clin Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei

Clin Lung Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
Igor Bychkov, Iuliia Topchu, Petr Makhov, Alexander Kudinov, Jyoti D Patel

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis